New radiation technique aims to cut treatment breaks for anal cancer patients
NCT ID NCT02701088
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 31 times
Summary
This study tests a newer radiation method (SIB-IMRT) combined with chemotherapy for people with advanced anal cancer. The goal is to see if this approach can reduce the need for treatment breaks while still controlling the cancer. About 71 adults with locally advanced anal cancer will take part, and researchers will track how well the cancer responds and how patients feel during and after treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED ANAL CANAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre Antoine Lacassagne
Nice, France
-
Centre François Baclesse
Caen, 14076, France
-
Centre Léon Berard
Lyon, France
-
Centre Paul Strauss
Strasbourg, France
-
IUCT-Oncopole
Toulouse, France
-
Institut de Cancérologie de Lorraine
Vandœuvre-lès-Nancy, 54519, France
-
Institut de Cancérologie de l'Ouest - Centre Paul Papin
Angers, France
-
Institut de cancérologie de l'Ouest
Saint-Herblain, 44805, France
Conditions
Explore the condition pages connected to this study.